Plitt A - Search Results

1

Cardioversion of Atrial Fibrillation in ENGAGE AF-TIMI 48.

Plitt A, Ezekowitz MD, De Caterina R, Nordio F, Peterson N, Giugliano RP; ENGAGE AF-TIMI 48 Investigators. Plitt A, et al. Clin Cardiol. 2016 Jun;39(6):345-6. doi: 10.1002/clc.22537. Epub 2016 Mar 30. Clin Cardiol. 2016. PMID: 27028520 Free PMC article. Clinical Trial. No abstract available.

2

Atrial Fibrillation, Type 2 Diabetes, and Non-Vitamin K Antagonist Oral Anticoagulants: A Review.

Plitt A, McGuire DK, Giugliano RP. Plitt A, et al. JAMA Cardiol. 2017 Apr 1;2(4):442-448. doi: 10.1001/jamacardio.2016.5224. JAMA Cardiol. 2017. PMID: 28122078 Review.

3

Major Bleeding in Patients With Diabetes and Atrial Fibrillation Treated With New Oral Anticoagulants-Reply.

Plitt A, McGuire DK, Giugliano RP. Plitt A, et al. JAMA Cardiol. 2017 Oct 1;2(10):1168. doi: 10.1001/jamacardio.2017.2034. JAMA Cardiol. 2017. PMID: 28658488 No abstract available.

4

Efficacy and safety of edoxaban in patients with diabetes mellitus in the ENGAGE AF-TIMI 48 trial.

Plitt A, Ruff CT, Goudev A, Morais J, Ostojic MC, Grosso MA, Lanz HJ, Park JG, Antman EM, Braunwald E, Giugliano RP. Plitt A, et al. Int J Cardiol. 2020 Apr 1;304:185-191. doi: 10.1016/j.ijcard.2020.01.009. Epub 2020 Jan 31. Int J Cardiol. 2020. PMID: 32008850 Clinical Trial.

5

Edoxaban: Review of pharmacology and key phase I to III clinical trials.

Plitt A, Giugliano RP. Plitt A, et al. J Cardiovasc Pharmacol Ther. 2014 Sep;19(5):409-16. doi: 10.1177/1074248414523675. Epub 2014 Mar 7. J Cardiovasc Pharmacol Ther. 2014. PMID: 24607764 Review.

6

Edoxaban or standard therapy with warfarin for stroke prevention in patients with atrial fibrillation?

Plitt A, Giugliano RP. Plitt A, et al. Future Cardiol. 2014 Mar;10(2):153-5. doi: 10.2217/fca.14.3. Future Cardiol. 2014. PMID: 24762238 No abstract available.

7

Target-specific oral anticoagulants: practice issues for the clinician.

Plitt A, Giugliano RP. Plitt A, et al. Hosp Pract (1995). 2014 Aug;42(3):48-61. doi: 10.3810/hp.2014.08.1117. Hosp Pract (1995). 2014. PMID: 25255406 Review.

8

Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation.

Plitt A, Ruff CT, Giugliano RP. Plitt A, et al. Hematol Oncol Clin North Am. 2016 Oct;30(5):1019-34. doi: 10.1016/j.hoc.2016.05.002. Hematol Oncol Clin North Am. 2016. PMID: 27637305 Review.

9

Cardiac sarcoidosis: case report, workup, and review of the literature.

Plitt A, Dorbala S, Albert MA, Giugliano RP. Plitt A, et al. Cardiol Ther. 2013 Dec;2(2):181-97. doi: 10.1007/s40119-013-0017-0. Epub 2013 Jun 18. Cardiol Ther. 2013. PMID: 25135396 Free PMC article.

10

Patients with diabetes mellitus and atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants: meta-analysis of eight outcomes in 58 634 patients across four randomized controlled trials.

Plitt A, Zelniker TA, Park JG, McGuire DK, Ruff CT, Antman EM, Braunwald E, Giugliano RP. Plitt A, et al. Eur Heart J Cardiovasc Pharmacother. 2021 Apr 9;7(FI1):f40-f49. doi: 10.1093/ehjcvp/pvaa120. Eur Heart J Cardiovasc Pharmacother. 2021. PMID: 33063112

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page